1st Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate Glaucomanews2021-12-15T14:15:50+00:00December 15th, 2021|Medical Device News Magazine|
